Abstract
The investigation of metal-containing drugs over several decades has set out to improve upon the toxicity and efficacy of conventional chemotherapeutic agents. Promising pre-clinical and clinical data have fostered the broadening for the search of metal compounds in cancer treatment and combination therapy. Gallium is only second to platinum in terms of anti-tumor activity. Its subsequent investigation has been ongoing for nearly three decades, primarily in the form of salts, and more recently coordinated to organic ligands as coordination complexes. From its early investigation as a diagnostic agent to its anti-tumor potential, promising clinical results have shown a renewed interest in exploring gallium in a host of malignancies, especially lymphoma and bladder cancer. However, the detailed mechanisms of action of gallium compounds are not completely defined. Further understanding the underlying mechanisms along with optimizing the structural components of gallium complexes will further improve the therapeutic index of gallium.
Keywords: Gallium, Gallium Complexes, Drug design, Drug discovery, Metal complexes, Ligands
Letters in Drug Design & Discovery
Title: The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug Design
Volume: 4 Issue: 5
Author(s): Michael Frezza, Claudio N. Verani, Di Chen and Q. Ping Dou
Affiliation:
Keywords: Gallium, Gallium Complexes, Drug design, Drug discovery, Metal complexes, Ligands
Abstract: The investigation of metal-containing drugs over several decades has set out to improve upon the toxicity and efficacy of conventional chemotherapeutic agents. Promising pre-clinical and clinical data have fostered the broadening for the search of metal compounds in cancer treatment and combination therapy. Gallium is only second to platinum in terms of anti-tumor activity. Its subsequent investigation has been ongoing for nearly three decades, primarily in the form of salts, and more recently coordinated to organic ligands as coordination complexes. From its early investigation as a diagnostic agent to its anti-tumor potential, promising clinical results have shown a renewed interest in exploring gallium in a host of malignancies, especially lymphoma and bladder cancer. However, the detailed mechanisms of action of gallium compounds are not completely defined. Further understanding the underlying mechanisms along with optimizing the structural components of gallium complexes will further improve the therapeutic index of gallium.
Export Options
About this article
Cite this article as:
Frezza Michael, Verani N. Claudio, Chen Di and Dou Q. Ping, The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug Design, Letters in Drug Design & Discovery 2007; 4 (5) . https://dx.doi.org/10.2174/157018007780867799
DOI https://dx.doi.org/10.2174/157018007780867799 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer
Anti-Cancer Agents in Medicinal Chemistry Issues Impacting Therapeutic Outcomes in Pediatric Patients: An Overview
Current Pediatric Reviews The Therapeutic Potential of Adenosine Triphosphate as an Immune Modulator in the Treatment of HIV/AIDS: A Combination Approach with HAART
Current HIV Research Human 5-HT4 and 5-HT7 Receptor Splice Variants: Are they Important?
Current Neuropharmacology Imaging with Raman Spectroscopy
Current Pharmaceutical Biotechnology The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors
Current Drug Safety Marine Metabolites Overcoming or Circumventing Multidrug Resistance Mediated by ATP-Dependent Transporters: A New Hope for Patient with Tumors Resistant to Conventional Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Inorganic Nanoparticles for In Vitro Cancer Diagnosis: A Patent Review
Recent Patents on Nanomedicine Metallothioneins and Platinum(II) Anti-Tumor Compounds
Current Medicinal Chemistry Antisense Treatment in Human Prostate Cancer and Melanoma
Current Cancer Drug Targets Collagen: The Oldest Scaffold for Tissue Regeneration
Current Tissue Engineering (Discontinued) Biopharmaceutics and Therapeutic Potential of Engineered Nanomaterials
Current Drug Metabolism Recent Developments in Targeted Therapies of the RAF-MEK and PI3KAKT Pathways in Cancer Treatment
Current Cancer Therapy Reviews Histone Deacetylase Inhibition: A Differentiation Therapy for Cultured Primary Hepatocytes?
Current Enzyme Inhibition Minimally Invasive Approach to Endometrial Cancer: Robotics and Laparoscopy
Current Women`s Health Reviews Vitamin E and All-Cause Mortality: A Meta-Analysis
Current Aging Science β3-Adrenergic Receptors: Really Relevant Targets for Anti-Obesity Drugs?
Current Medicinal Chemistry - Central Nervous System Agents Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery Elucidation of the Chemopreventive Role of Stigmasterol Against Jab1 in Gall Bladder Carcinoma
Endocrine, Metabolic & Immune Disorders - Drug Targets